1. Home
  2. DKS vs BBIO Comparison

DKS vs BBIO Comparison

Compare DKS & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dick's Sporting Goods Inc

DKS

Dick's Sporting Goods Inc

N/A

Current Price

$196.07

Market Cap

18.6B

ML Signal

N/A

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

N/A

Current Price

$71.45

Market Cap

15.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DKS
BBIO
Founded
1948
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.6B
15.3B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
DKS
BBIO
Price
$196.07
$71.45
Analyst Decision
Buy
Strong Buy
Analyst Count
19
24
Target Price
$241.50
$83.00
AVG Volume (30 Days)
1.0M
2.8M
Earning Date
01-01-0001
05-22-2026
Dividend Yield
2.49%
N/A
EPS Growth
15.35
N/A
EPS
8.66
N/A
Revenue
$13,442,849,000.00
$502,076,000.00
Revenue This Year
$30.99
$88.86
Revenue Next Year
$26.26
$74.11
P/E Ratio
$22.47
N/A
Revenue Growth
3.53
126.26
52 Week Low
$166.37
$28.33
52 Week High
$237.31
$84.94

Technical Indicators

Market Signals
Indicator
DKS
BBIO
Relative Strength Index (RSI) 39.29 52.30
Support Level $168.88 $70.65
Resistance Level $233.78 $79.56
Average True Range (ATR) 6.89 3.33
MACD -1.19 0.67
Stochastic Oscillator 20.60 65.78

Price Performance

Historical Comparison
DKS
BBIO

About DKS Dick's Sporting Goods Inc

Dick's Sporting Goods is a retailer that offers sports and outdoor apparel, footwear, and equipment online and in physical stores. The company's legacy business includes more than 700 stores under its own name, more than 110 Golf Galaxy golf specialty stores, and about 50 outlet stores. In September 2025, Dick's acquired multinational retailer Foot Locker. With this move, Dick's added about 2,600 stores under the Foot Locker, Kids Foot Locker, Champs Sports, atmos, and WSS nameplates in North America, the Asia-Pacific, and EMEA—Europe, the Middle East, and Africa. Based in the Pittsburgh area, Dick's was founded in 1948 by the father of current executive chair and controlling shareholder Edward Stack.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: